Development and Testing of the Kidney BEAM-KIDS Digital Platform for Children After Kidney Transplantation (BEAM-KIDs)

November 16, 2023 updated by: Pelagia Koufaki, PhD, Queen Margaret University

Co-design, Development and Evaluation of the KIDNEY BEAM-KIDS Platform for Paediatric Kidney Transplant Recipients: a Feasibility Study

Children and young people (CYP) with chronic kidney disease (CKD) say that physical activity, school, social activities and tiredness are the main issues they want to improve. Kidney-BEAM, a digital health platform designed for adults with CKD, provides a combination of live and on-demand exercise classes to encourage physical activity and movement but is currently not available to CYP with CKD. Therefore, investigators will work with CYP with CKD, parents/carers and healthcare professionals to find out if a CYP-related version (Kidney BEAM-KIDS), could be developed to encourage exercise options that are enjoyable, safe and sustainable. In this project, CYP who have received a KT will be invited by their local clinical teams to try out Kidney BEAM-KIDS; this will include exercise-based classes delivered in age-appropriate groups where CYP will be able to get peer support. Kidney BEAM-KIDS will include features to help motivation such as badges and celebrations when reaching targets. The CYP will be asked to participate in discussions and complete several questionnaires at three time-points over 12 months to explore how CYP feel about themselves and aspects of their lives such as friendships and school, how physically active they are, their preferred types of foods, activities they do, and their health. This will help the investigators a) understand how acceptable Kidney BEAM-KIDS is to CYP, b) determine whether it needs any changes/improvements, and c) identify key issues around how best to gather data and answer research questions about physical activity benefits in CYP with CKD.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Kidney transplantation (KT) is the preferred and most prevalent treatment in CYP with CKD but is associated with increased risk of cardiovascular complications, insulin resistance, and diabetes, with likely contributors being visceral obesity and low lean body mass. In general paediatric populations, all of the above are favourably modified by regular/varied PA. The benefits and risks of PA for CYP with CKD are, however, less well established and available data are mainly from cross-sectional studies. Kidney-BEAM is a digital health platform for adults with CKD, which provides live and on-demand exercise classes. The investigators propose to adapt the kidney BEAM platform to kidney BEAM-KIDS for CYP with CKD to access activities adapted to their needs and document benefits on outcomes that matter to them.

Aims and methods: A single-arm, multi-centre, feasibility study, with a mixed-method design using an effectiveness and theory-based perspective. Investigators will examine the feasibility and acceptability of (a) Kidney BEAM-KIDS as the intervention and delivery setting in CYP following KT, and (b) the evaluation design for addressing all recommended core elements (context, engaging stakeholders, identifying key uncertainties, refining the intervention, economic considerations) to inform the development of a clinical evaluation trial The team will aim to recruit about 30 participants between 6-17 years of age. Research questions:

  1. What are participants' experiences of Kidney BEAM-KIDS and views on its feasibility, acceptability and benefits?
  2. What type and quantity of adverse events (if any) are experienced over an observation period of 7-12 months?
  3. What are the study recruitment and retention rates?
  4. What is the acceptability of data collection methods and rate of outcome measure completion?
  5. What are the variability and patterns of change in outcomes to determine a primary outcome measure and calculate sample size for a future study?
  6. What is the feasibility of a future health economic evaluation?

Outcomes: Quantitive data: demographic, clinical and physical characteristics, adverse events and hospitalisations, 4-7 day dietary intake diaries, at 3 time points: before and after KT and after 12 weeks exposure to Kidney BEAM-KIDS. Selection of outcomes was based on i) the potential impact on outcomes that matter to CYP (multidimensional PedsQLv4, self perception profile, Physical activity questionnaire, BEAM-KIDS platform use metrics), (ii) participants' wide age range (6-17 years), and iii) the need to minimise face-to-face assessments where possible due to the wide geographical spread of recruiting centres. Physical function outcomes (strength and cardiorespitatory fitness) will be collected in person if possible. Qualitative data: via remote semi-structured individual interviews and focus groups using a process evaluation approach to explore experiences, attitudes, preferences, suggestions to inform future directions.

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Glasgow, United Kingdom
        • Recruiting
        • Glasgow Royal Hospital for Children
        • Contact:
          • Reynolds

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 17 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • CYP of school age between 6 and 17 years attending a paediatric transplant centre
  • Likely to require a KT within 12 months
  • No intended date of transition to adult services within 12 months

Exclusion Criteria:

  • Inability or absolute contraindications to engaging in PA
  • Severe bone disease
  • Cancer/leukaemia or HIV treatment within the 12 months before enrolment
  • Enrolment in other clinical trials in which treatment is masked.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: exercise
live and on demand exercise sessions on the Kidney BEAM-KIDS platform
physical activity promotion and engagement following kidney transplantation
Other Names:
  • kidney transplantation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of Life score
Time Frame: change from baseline to 12 and 24 weeks post kidney transplantation and exercise
the multidimensional PedsQLv4 questionnaire and relevant sub-module questionnaires on fatigue and transplantation will be used to estimate scores that reflect the domains of physical functioning, emotional functioning, social functioning, school functioning, general fatigue, sleep/rest fatigue and cognitive fatigue, treatment anxiety
change from baseline to 12 and 24 weeks post kidney transplantation and exercise

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frequency and type of physical activity
Time Frame: change from baseline to 12 and 24 weeks post kidney transplantation and exercise
the self-reported Physical Activity Questionnaire - PAQ for CYP will be used to capture data on PA patterns
change from baseline to 12 and 24 weeks post kidney transplantation and exercise
type and quantity of food groups consumed
Time Frame: change from baseline to 12 and 24 weeks post kidney transplantation and exercise
4-7 day diaries will be used to capture and analyse nutritional intake information
change from baseline to 12 and 24 weeks post kidney transplantation and exercise
adverse events
Time Frame: change from baseline to 12 and 24 weeks post kidney transplantation and exercise
episodes of hospitalisations and other infection events will be captured via medical records
change from baseline to 12 and 24 weeks post kidney transplantation and exercise
kidney BEAM-KIDS platform metrics
Time Frame: change from 12 weeks post kidney transplantation to 12 weeks post exercise
minutes spent on physical activity and engagement with the digital health platform
change from 12 weeks post kidney transplantation to 12 weeks post exercise
qualitative exploration of trial acceptability and participant experience
Time Frame: at 12 weeks post kidney transplantation
focus groups and semi structured interviews with participants and families will be used to capture qualitative data
at 12 weeks post kidney transplantation
qualitative exploration of trial acceptability and participant experience
Time Frame: at 12 weeks post exercise
focus groups and semi structured interviews with participants and families will be used to capture qualitative data
at 12 weeks post exercise

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 18, 2023

Primary Completion (Estimated)

October 31, 2024

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

June 20, 2022

First Submitted That Met QC Criteria

July 6, 2022

First Posted (Actual)

July 12, 2022

Study Record Updates

Last Update Posted (Estimated)

November 20, 2023

Last Update Submitted That Met QC Criteria

November 16, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • P2008QMU

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

no plan yet

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Kidney Transplantation

Clinical Trials on exercise

Subscribe